{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T13:06:54Z","timestamp":1793192814371,"version":"4.5.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T00:00:00Z","timestamp":1747008000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T00:00:00Z","timestamp":1747008000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["EXC 2167: CD-1, CD-2, TI-1"],"award-info":[{"award-number":["EXC 2167: CD-1, CD-2, TI-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["EXC 2167"],"award-info":[{"award-number":["EXC 2167"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["EXC 2167: RTF-VI"],"award-info":[{"award-number":["EXC 2167: RTF-VI"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["EXC 2167"],"award-info":[{"award-number":["EXC 2167"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["miTARGET (RU5042)"],"award-info":[{"award-number":["miTARGET (RU5042)"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["SO1141\/10-1"],"award-info":[{"award-number":["SO1141\/10-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["SFB1470, SFB1449"],"award-info":[{"award-number":["SFB1470, SFB1449"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["miTARGET (RU5042)"],"award-info":[{"award-number":["miTARGET (RU5042)"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["EXC 2167: CD-1, CD-2, TI-1"],"award-info":[{"award-number":["EXC 2167: CD-1, CD-2, TI-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["EXC 2167: CD-2, RTF-VI, TI-1"],"award-info":[{"award-number":["EXC 2167: CD-2, RTF-VI, TI-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["e:Med Juniorverbund \u201cTry-IBD\u201d 01ZX1915A and 01ZX2215, e:Med Network iTREAT 01ZX2202A"],"award-info":[{"award-number":["e:Med Juniorverbund \u201cTry-IBD\u201d 01ZX1915A and 01ZX2215, e:Med Network iTREAT 01ZX2202A"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["e:Med CKDNapp 01ZX1912A"],"award-info":[{"award-number":["e:Med CKDNapp 01ZX1912A"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["e:Med Juniorverbund \u201cTry-IBD\u201d 01ZX1915A and 01ZX2215, e:Med Network iTREAT 01ZX2202A"],"award-info":[{"award-number":["e:Med Juniorverbund \u201cTry-IBD\u201d 01ZX1915A and 01ZX2215, e:Med Network iTREAT 01ZX2202A"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["e:Med Juniorverbund \u201cTry-IBD\u201d 01ZX1915A and 01ZX2215, e:Med Network iTREAT 01ZX2202A"],"award-info":[{"award-number":["e:Med Juniorverbund \u201cTry-IBD\u201d 01ZX1915A and 01ZX2215, e:Med Network iTREAT 01ZX2202A"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002869","name":"Christian-Albrechts-Universit\u00e4t zu Kiel","doi-asserted-by":"publisher","award":["K126408"],"award-info":[{"award-number":["K126408"]}],"id":[{"id":"10.13039\/501100002869","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010447","name":"Deutsches Zentrum f\u00fcr Herz-Kreislaufforschung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010447","id-type":"DOI","asserted-by":"publisher"}]},{"name":"See funding for individual authors."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Metab"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Cellular NAD\n                    <jats:sup>+<\/jats:sup>\n                    depletion, altered tryptophan metabolism and gut microbiome dysbiosis are associated with disease progression and unfavourable clinical outcomes in COVID-19. Here, we show that supplementing tryptophan metabolism with nicotinamide alleviates COVID-19 symptoms. We evaluate a 4-week intervention with a novel nicotinamide formulation (1,000\u2009mg) in a prospective, double-blind, randomized, placebo-controlled trial in 900 symptomatic outpatients with PCR-proven COVID-19. In the primary analysis population of participants at risk for severe COVID-19, 57.6% of those receiving nicotinamide and 42.6% receiving placebo recover from their performance drop at week 2 (\n                    <jats:italic>P<\/jats:italic>\n                    \u2009=\u20090.004). Nicotinamide is also beneficial for returning to normal activities (\n                    <jats:italic>P<\/jats:italic>\n                    \u2009=\u20090.009). Effects on gut metagenomic signatures parallel clinical efficacy, suggesting that nicotinamide influences COVID-19-associated faecal microbiome changes. After 6 months, responders to nicotinamide in acute COVID-19 show fewer post-COVID symptoms than placebo responders (\n                    <jats:italic>P<\/jats:italic>\n                    \u2009=\u20090.010). No relevant safety signals are observed. Overall, our results show that nicotinamide leads to faster recovery of physical performance and modulates COVID-19-associated faecal microbiome changes.\n                  <\/jats:p>","DOI":"10.1038\/s42255-025-01290-1","type":"journal-article","created":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T05:03:37Z","timestamp":1747026217000},"page":"1136-1149","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Nicotinamide modulates gut microbial metabolic potential and accelerates recovery in mild-to-moderate COVID-19"],"prefix":"10.1038","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2254-7771","authenticated-orcid":false,"given":"Stefan","family":"Schreiber","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg H.","family":"Waetzig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00edctor A.","family":"L\u00f3pez-Agudelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinna","family":"Geisler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0281-5142","authenticated-orcid":false,"given":"Kristina","family":"Schlicht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sina","family":"Franzenburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romina","family":"di Giuseppe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Pape","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Bahmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Krawczak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Kokott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8194-3777","authenticated-orcid":false,"given":"Josef M.","family":"Penninger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Harzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Kramer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tammo","family":"von Schrenck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6545-3487","authenticated-orcid":false,"given":"Felix","family":"Sommer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3633-1330","authenticated-orcid":false,"given":"Helena U.","family":"Zacharias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"COVit-2 Study Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernd","family":"Bokemeyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romina","family":"di Giuseppe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfram","family":"Gronwald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle M. M.","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Hartmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Hollstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J.","family":"Oefner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Plachta-Danielzik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tammo","family":"von Schrenck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4287-282X","authenticated-orcid":false,"given":"Bel\u00e9n","family":"Millet Pascual-Leone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4285-6993","authenticated-orcid":false,"given":"Sofia K.","family":"Forslund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Heyckendorf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3482-7316","authenticated-orcid":false,"given":"Konrad","family":"Aden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regina","family":"Hollweck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7846-955X","authenticated-orcid":false,"given":"Matthias","family":"Laudes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9692-8828","authenticated-orcid":false,"given":"Philip","family":"Rosenstiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,12]]},"reference":[{"key":"1290_CR1","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/s42255-021-00507-3","volume":"4","author":"C Brenner","year":"2022","unstructured":"Brenner, C. Viral infection as an NAD+ battlefield. Nat. Metab. 4, 2\u20133 (2022).","journal-title":"Nat. Metab."},{"key":"1290_CR2","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.it.2022.02.001","volume":"43","author":"M Zheng","year":"2022","unstructured":"Zheng, M., Schultz, M. B. & Sinclair, D. A. NAD+ in COVID-19 and viral infections. Trends Immunol. 43, 283\u2013295 (2022).","journal-title":"Trends Immunol."},{"key":"1290_CR3","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1146\/annurev.nutr.28.061807.155443","volume":"28","author":"KL Bogan","year":"2008","unstructured":"Bogan, K. L. & Brenner, C. Nicotinic acid, nicotinamide, and nicotinamide riboside: a molecular evaluation of NAD+ precursor vitamins in human nutrition. Annu. Rev. Nutr. 28, 115\u2013130 (2008).","journal-title":"Annu. Rev. Nutr."},{"key":"1290_CR4","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.3390\/ijms22041597","volume":"22","author":"G Anderson","year":"2021","unstructured":"Anderson, G., Carbone, A. & Mazzoccoli, G. Tryptophan metabolites and aryl hydrocarbon receptor in severe acute respiratory syndrome, coronavirus-2 (SARS-CoV-2) pathophysiology. Int. J. Mol. Sci. 22, 1597 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"1290_CR5","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1038\/s41385-020-00361-8","volume":"14","author":"V Sencio","year":"2021","unstructured":"Sencio, V., Machado, M. G. & Trottein, F. The lung\u2013gut axis during viral respiratory infections: the impact of gut dysbiosis on secondary disease outcomes. Mucosal Immunol. 14, 296\u2013304 (2021).","journal-title":"Mucosal Immunol."},{"key":"1290_CR6","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.3390\/biomedicines10061332","volume":"10","author":"M Chilosi","year":"2022","unstructured":"Chilosi, M. et al. Unbalanced IDO1\/IDO2 endothelial expression and skewed keynurenine pathway in the pathogenesis of COVID-19 and post-COVID-19 pneumonia. Biomedicines 10, 1332 (2022).","journal-title":"Biomedicines"},{"key":"1290_CR7","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1515\/cclm-2016-0912","volume":"55","author":"MA Meier","year":"2017","unstructured":"Meier, M. A. et al. Activation of the tryptophan\/serotonin pathway is associated with severity and predicts outcomes in pneumonia: results of a long-term cohort study. Clin. Chem. Lab. Med. 55, 1060\u20131069 (2017).","journal-title":"Clin. Chem. Lab. Med."},{"key":"1290_CR8","doi-asserted-by":"publisher","first-page":"41","DOI":"10.4137\/IJTR.S26862","volume":"8","author":"V Mehraj","year":"2015","unstructured":"Mehraj, V. & Routy, J. P. Tryptophan catabolism in chronic viral infections: handling uninvited guests. Int. J. Tryptophan Res. 8, 41\u201348 (2015).","journal-title":"Int. J. Tryptophan Res."},{"key":"1290_CR9","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/j.chom.2018.05.003","volume":"23","author":"A Agus","year":"2018","unstructured":"Agus, A., Planchais, J. & Sokol, H. Gut microbiota regulation of tryptophan metabolism in health and disease. Cell Host Microbe 23, 716\u2013724 (2018).","journal-title":"Cell Host Microbe"},{"key":"1290_CR10","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1016\/j.jcmgh.2021.06.014","volume":"12","author":"WH Qin","year":"2021","unstructured":"Qin, W. H. et al. Gut ACE2 expression, tryptophan deficiency, and inflammatory responses the potential connection that should not be ignored during SARS-CoV-2 infection. Cell. Mol. Gastroenterol. Hepatol. 12, 1514\u20131516 (2021).","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"1290_CR11","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1136\/gutjnl-2020-323020","volume":"70","author":"YK Yeoh","year":"2021","unstructured":"Yeoh, Y. K. et al. Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19. Gut 70, 698\u2013706 (2021).","journal-title":"Gut"},{"key":"1290_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-33395-6","volume":"13","author":"L Bernard-Raichon","year":"2022","unstructured":"Bernard-Raichon, L. et al. Gut microbiome dysbiosis in antibiotic-treated COVID-19 patients is associated with microbial translocation and bacteremia. Nat. Commun. 13, 5926 (2022).","journal-title":"Nat. Commun."},{"key":"1290_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-34535-8","volume":"13","author":"Q Liu","year":"2022","unstructured":"Liu, Q. et al. Multi-kingdom gut microbiota analyses define COVID-19 severity and post-acute COVID-19 syndrome. Nat. Commun. 13, 6806 (2022).","journal-title":"Nat. Commun."},{"key":"1290_CR14","doi-asserted-by":"publisher","first-page":"S1571","DOI":"10.1016\/S0016-5085(23)04756-X","volume":"164","author":"RI Lau","year":"2023","unstructured":"Lau, R. I. et al. Modulation of gut microbiome alleviates post-acute COVID-19 syndrome: a randomised, triple-blind, placebo-controlled trial (RECOVERY study). Gastroenterology 164, S1571\u2013S1572 (2023).","journal-title":"Gastroenterology"},{"key":"1290_CR15","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1111\/imr.12567","volume":"279","author":"JM Pickard","year":"2017","unstructured":"Pickard, J. M., Zeng, M. Y., Caruso, R. & Nunez, G. Gut microbiota: role in pathogen colonization, immune responses, and inflammatory disease. Immunol. Rev. 279, 70\u201389 (2017).","journal-title":"Immunol. Rev."},{"key":"1290_CR16","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/nrmicro.2016.142","volume":"15","author":"KF Budden","year":"2017","unstructured":"Budden, K. F. et al. Emerging pathogenic links between microbiota and the gut\u2013lung axis. Nat. Rev. Microbiol. 15, 55\u201363 (2017).","journal-title":"Nat. Rev. Microbiol."},{"key":"1290_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41522-024-00538-0","volume":"10","author":"M Essex","year":"2024","unstructured":"Essex, M. et al. Gut microbiota dysbiosis is associated with altered tryptophan metabolism and dysregulated inflammatory response in COVID-19. NPJ Biofilms Microbiomes 10, 66 (2024).","journal-title":"NPJ Biofilms Microbiomes"},{"key":"1290_CR18","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/nature11228","volume":"487","author":"T Hashimoto","year":"2012","unstructured":"Hashimoto, T. et al. ACE2 links amino acid malnutrition to microbial ecology and intestinal inflammation. Nature 487, 477\u2013481 (2012).","journal-title":"Nature"},{"key":"1290_CR19","unstructured":"Waetzig, G. & Seegert, D. A pharmaceutical composition containing nicotinic acid and\/or nicotinamide and\/or tryptophan for positively influencing the intestinal microbiota. PCT patent application no. PCT\/EP2013\/062363 (2013)."},{"key":"1290_CR20","doi-asserted-by":"publisher","first-page":"17986","DOI":"10.1074\/jbc.RA120.015138","volume":"295","author":"CD Heer","year":"2020","unstructured":"Heer, C. D. et al. Coronavirus infection and PARP expression dysregulate the NAD metabolome: an actionable component of innate immunity. J. Biol. Chem. 295, 17986\u201317996 (2020).","journal-title":"J. Biol. Chem."},{"key":"1290_CR21","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1186\/s12859-016-1323-z","volume":"17","author":"GE Hoffman","year":"2016","unstructured":"Hoffman, G. E. & Schadt, E. E. variancePartition: interpreting drivers of variation in complex gene expression studies. BMC Bioinf. 17, 483 (2016).","journal-title":"BMC Bioinf."},{"key":"1290_CR22","doi-asserted-by":"publisher","first-page":"e65088","DOI":"10.7554\/eLife.65088","volume":"10","author":"F Beghini","year":"2021","unstructured":"Beghini, F. et al. Integrating taxonomic, functional, and strain-level profiling of diverse microbial communities with bioBakery 3. eLife 10, e65088 (2021).","journal-title":"eLife"},{"key":"1290_CR23","doi-asserted-by":"publisher","first-page":"101549","DOI":"10.1016\/j.eclinm.2022.101549","volume":"51","author":"T Bahmer","year":"2022","unstructured":"Bahmer, T. et al. Severity, predictors and clinical correlates of post-COVID syndrome (PCS) in Germany: a prospective, multi-centre, population-based cohort study. EClinicalMedicine 51, 101549 (2022).","journal-title":"EClinicalMedicine"},{"key":"1290_CR24","doi-asserted-by":"publisher","first-page":"e0259164","DOI":"10.1371\/journal.pone.0259164","volume":"16","author":"AN Poudel","year":"2021","unstructured":"Poudel, A. N. et al. Impact of COVID-19 on health-related quality of life of patients: a structured review. PLoS ONE 16, e0259164 (2021).","journal-title":"PLoS ONE"},{"key":"1290_CR25","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1016\/S2213-2600(21)00383-0","volume":"9","author":"RA Evans","year":"2021","unstructured":"Evans, R. A. et al. Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study. Lancet Respir. Med. 9, 1275\u20131287 (2021).","journal-title":"Lancet Respir. Med."},{"key":"1290_CR26","doi-asserted-by":"publisher","first-page":"e0277984","DOI":"10.1371\/journal.pone.0277984","volume":"17","author":"S Vollrath","year":"2022","unstructured":"Vollrath, S. et al. Recovery of performance and persistent symptoms in athletes after COVID-19. PLoS ONE 17, e0277984 (2022).","journal-title":"PLoS ONE"},{"key":"1290_CR27","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.pulmoe.2021.06.005","volume":"27","author":"C Simonelli","year":"2021","unstructured":"Simonelli, C., Paneroni, M., Vitacca, M. & Ambrosino, N. Measures of physical performance in COVID-19 patients: a mapping review. Pulmonology 27, 518\u2013528 (2021).","journal-title":"Pulmonology"},{"key":"1290_CR28","unstructured":"WHO. R&D Blueprint Novel Coronavirus COVID-19 Therapeutic Trial Synopsis https:\/\/www.who.int\/publications\/i\/item\/covid-19-therapeutic-trial-synopsis (World Health Organization, 2020)."},{"key":"1290_CR29","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1016\/j.jval.2018.03.013","volume":"21","author":"I Montan","year":"2018","unstructured":"Montan, I., Lowe, B., Cella, D., Mehnert, A. & Hinz, A. General Population Norms for the Functional Assessment of Chronic Illness Therapy (FACIT)\u2014fatigue scale. Value Health 21, 1313\u20131321 (2018).","journal-title":"Value Health"},{"key":"1290_CR30","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1086\/367544","volume":"36","author":"MF Murray","year":"2003","unstructured":"Murray, M. F. Nicotinamide: an oral antimicrobial agent with activity against both Mycobacterium tuberculosis and human immunodeficiency virus. Clin. Infect. Dis. 36, 453\u2013460 (2003).","journal-title":"Clin. Infect. Dis."},{"key":"1290_CR31","doi-asserted-by":"publisher","DOI":"10.1177\/2515690X211036875","volume":"26","author":"M Hermel","year":"2021","unstructured":"Hermel, M. et al. Natural supplements for COVID19\u2014background, rationale, and clinical trials. J. Evid. Based Integr. Med. 26, 2515690X211036875 (2021).","journal-title":"J. Evid. Based Integr. Med."},{"key":"1290_CR32","doi-asserted-by":"publisher","first-page":"747816","DOI":"10.3389\/fcimb.2021.747816","volume":"11","author":"J Reinold","year":"2021","unstructured":"Reinold, J. et al. A pro-inflammatory gut microbiome characterizes SARS-CoV-2 infected patients and a reduction in the connectivity of an anti-inflammatory bacterial network associates with severe COVID-19. Front. Cell. Infect. Microbiol. 11, 747816 (2021).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"1290_CR33","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1053\/j.gastro.2022.09.024","volume":"164","author":"N Nagata","year":"2023","unstructured":"Nagata, N. et al. Human gut microbiota and its metabolites impact immune responses in COVID-19 and its complications. Gastroenterology 164, 272\u2013288 (2023).","journal-title":"Gastroenterology"},{"key":"1290_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-023-01202-6","volume":"15","author":"LH Nguyen","year":"2023","unstructured":"Nguyen, L. H. et al. Metagenomic assessment of gut microbial communities and risk of severe COVID-19. Genome Med. 15, 49 (2023).","journal-title":"Genome Med."},{"key":"1290_CR35","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1053\/j.gastro.2020.05.048","volume":"159","author":"T Zuo","year":"2020","unstructured":"Zuo, T. et al. Alterations in gut microbiota of patients with COVID-19 during time of hospitalization. Gastroenterology 159, 944\u2013955 (2020).","journal-title":"Gastroenterology"},{"key":"1290_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-26500-8","volume":"12","author":"V Llorens-Rico","year":"2021","unstructured":"Llorens-Rico, V. et al. Clinical practices underlie COVID-19 patient respiratory microbiome composition and its interactions with the host. Nat. Commun. 12, 6243 (2021).","journal-title":"Nat. Commun."},{"key":"1290_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-023-01472-7","volume":"11","author":"L de Nies","year":"2023","unstructured":"de Nies, L. et al. Altered infective competence of the human gut microbiome in COVID-19. Microbiome 11, 46 (2023).","journal-title":"Microbiome"},{"key":"1290_CR38","doi-asserted-by":"publisher","first-page":"ycae042","DOI":"10.1093\/ismeco\/ycae042","volume":"4","author":"J Rivas-Santisteban","year":"2024","unstructured":"Rivas-Santisteban, J. et al. Quantifying microbial guilds. ISME Commun. 4, ycae042 (2024).","journal-title":"ISME Commun."},{"key":"1290_CR39","doi-asserted-by":"publisher","first-page":"2018899","DOI":"10.1080\/19490976.2021.2018899","volume":"14","author":"P Gutierrez-Castrellon","year":"2022","unstructured":"Gutierrez-Castrellon, P. et al. Probiotic improves symptomatic and viral clearance in COVID19 outpatients: a randomized, quadruple-blinded, placebo-controlled trial. Gut Microbes 14, 2018899 (2022).","journal-title":"Gut Microbes"},{"key":"1290_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-51528-3","volume":"14","author":"R Ohue-Kitano","year":"2024","unstructured":"Ohue-Kitano, R., Banno, Y., Masujima, Y. & Kimura, I. Gut microbial metabolites reveal diet-dependent metabolic changes induced by nicotine administration. Sci. Rep. 14, 1056 (2024).","journal-title":"Sci. Rep."},{"key":"1290_CR41","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1007\/s00203-018-1506-2","volume":"200","author":"Z Savin","year":"2018","unstructured":"Savin, Z., Kivity, S., Yonath, H. & Yehuda, S. Smoking and the intestinal microbiome. Arch. Microbiol. 200, 677\u2013684 (2018).","journal-title":"Arch. Microbiol."},{"key":"1290_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2024.105056","volume":"102","author":"DMM Harris","year":"2024","unstructured":"Harris, D. M. M. et al. Tryptophan degradation as a systems phenomenon in inflammation\u2014an analysis across 13 chronic inflammatory diseases. EBioMedicine 102, 105056 (2024).","journal-title":"EBioMedicine"},{"key":"1290_CR43","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.jhin.2023.01.011","volume":"134","author":"B Suwono","year":"2023","unstructured":"Suwono, B., Brandl, M., Hecht, J., Eckmanns, T. & Haller, S. Epidemiology of healthcare-associated SARS-CoV-2 outbreaks in Germany between March 2020 and May 2022. J. Hosp. Infect. 134, 108\u2013120 (2023).","journal-title":"J. Hosp. Infect."},{"key":"1290_CR44","doi-asserted-by":"publisher","unstructured":"Kaehler, B. D. Silva 138.1 taxonomy classifiers for use with QIIME 2 q2-feature-classifier. Zenodo https:\/\/doi.org\/10.1038\/s41467-019-12669-6 (2019).","DOI":"10.1038\/s41467-019-12669-6"}],"container-title":["Nature Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42255-025-01290-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42255-025-01290-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42255-025-01290-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T10:01:40Z","timestamp":1750845700000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42255-025-01290-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,12]]},"references-count":44,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,6]]}},"alternative-id":["1290"],"URL":"https:\/\/doi.org\/10.1038\/s42255-025-01290-1","relation":{},"ISSN":["2522-5812"],"issn-type":[{"value":"2522-5812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,12]]},"assertion":[{"value":"21 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"S.S. reports indirect stock ownership in Gerion Biotech as well as consulting and personal fees from AbbVie, Allergosan, Amgen, Arena, BMS, Biogen, Celltrion, Celgene, Falk, Ferring, Fresenius, Galapagos\/Gilead, HIKMA, I-Mab, Janssen, Lilly, Morphic, MSD, Mylan, Pfizer, Prometheus, Protagonist, Provention Bio, Sandoz\/Hexal, Takeda and Theravance. G.H.W. is employed part-time by the CONARIS Research Institute AG (Kiel, Germany). T.B. reports consulting fees, honoraria or other support from AstraZeneca, Boehringer-Ingelheim, Chiesi, GlaxoSmithKline, Merck, MSD, Novartis, Pfizer and Roche. J.M.P. reports stock ownership in Apeiron Biologics and JLP Health. K.A. reports consulting fees, honoraria or other support from AbbVie, Falk, Galapagos, Janssen, Pfizer and Takeda. M.L. reports a lecture honorarium and travel support by AstraZeneca. P.R. reports stock ownership in Gerion Biotech and consulting fees from Takeda. Additional authors of the COVit-2 Study Group: B.B. reports grants, contracts, consulting fees, honoraria or other support from AbbVie, Arena, BMS, Falk, Ferring, Galapagos, Janssen, MSD and Takeda. D.P. reports meeting support from Advanz Pharma. F.T. reports consulting fees, honoraria or other support from AbbVie, Falk, Janssen, L.E.K. Consulting, Lilly and Sanofi. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}